arrow
M

Michael C. Sierant

Biomarin Pharmaceutical
H指数:10
被引数:1,550

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genomic analysis of 11,555 probands identifies 60 dominant congenital heart disease genes

11,555例先证者的基因组分析鉴定出60个显性先天性心脏病基因

2025-03-240
OA
Somatic PIK3CA Mutations in Sporadic Cerebral Cavernous Malformations

散发性脑海绵状畸形中的体细胞PIK3CA突变

2021-09-0959
OA
Mutations disrupting neuritogenesis genes confer risk for cerebral palsy (vol 52, pg 1046, 2020)
2021-01-111
OAAI
Exome sequencing implicates genetic disruption of prenatal neuro-gliogenesis in sporadic congenital hydrocephalus
2020-10-19100
OAAI
Mutations disrupting neuritogenesis genes confer risk for cerebral palsy
2020-09-28105
OAAI
Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands
2017-10-09606
OAAI